Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.02.2023 | Case report

Venetoclax misuse

Tumour lysis syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Melo IT, et al. USO INADEQUADO DE VENETOCLAX COMO CAUSA DE SINDROME DE LISE TUMORAL E EMERGENCIA DIALITICA EM PACIENTE COM DIAGNOSTICO DE LEUCEMIA LINFOCITICA CRONICA. Hematology, Transfusion and Cell Therapy 44 (Suppl. 2): S136, Oct 2022. Available from: URL: http://doi.org/10.1016/j.htct.2022.09.229 [abstract] Melo IT, et al. USO INADEQUADO DE VENETOCLAX COMO CAUSA DE SINDROME DE LISE TUMORAL E EMERGENCIA DIALITICA EM PACIENTE COM DIAGNOSTICO DE LEUCEMIA LINFOCITICA CRONICA. Hematology, Transfusion and Cell Therapy 44 (Suppl. 2): S136, Oct 2022. Available from: URL: http://​doi.​org/​10.​1016/​j.​htct.​2022.​09.​229 [abstract]
Metadaten
Titel
Venetoclax misuse
Tumour lysis syndrome: case report
Publikationsdatum
01.02.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-33512-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Azathioprine

Case report

Multiple drugs

Case report

Methotrexate